Patent Yard Sign in
Canadian application, no grantCanada

Liver fluke diagnostic system

CA 2089157 A1 · Owner: British Technology Group Limited · Inventors: Mcnair, Alan T.; Trudgett, Alan G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Current techniques for the diagnosis of liver fluke infection in animals involve examination of faecal matter for parasite eggs and as such are difficult to use outside a research environment. The invention provides an antibody-binding region of a liver fluke tegument protein comprising a peptide with an amino-acid sequence: Asparagine-Lysine-Glutamic acid-Glycine-Glutamic acid-Proline-Glutamic acid as well as antibodies raised against it. Either the antibody-binding sequence or antibodies raised against it can be used in a test system for the diagnosis of liver fluke infection.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 16, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 16, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 16, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 16, 1991
GrantedNo grant recorded
Term endedAugust 16, 2011
Patent numberCA 2089157 A1
Classification (IPC)C07K14/43 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedAug 16, 1991Term endedAug 16, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.